| Michael Zaki, MD | |
|
21097 Ne 27th Ct Ste 410, Aventura, FL 33180-1249 | |
| (305) 932-6375 | |
| Not Available |
| Full Name | Michael Zaki |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 9 Years |
| Location | 21097 Ne 27th Ct Ste 410, Aventura, Florida |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1992199814 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | ME142368 (Florida) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aventura Hospital And Medical Center | Aventura, FL | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| South Florida Ent Associates Inc | 4587556923 | 130 |
News Archive
Mylan N.V. and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding to its existing offering of Fentanyl Transdermal System 12, 25, 50, 75 and 100 mcg/hr.
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded a two-year grant to Dr. Brian L. Schmidt, professor of oral and maxillofacial surgery at the NYU College of Dentistry, and Dr. Donna G. Albertson, professor at the UCSF Helen Diller Family Comprehensive Cancer Center. The grant will fund groundbreaking research to customize treatment for oral cancer patients.
Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.
The Black Death swept Europe in the 14th century eliminating up to half of the population but it left genetic clues that now may aid a University of Cincinnati researcher in treating HIV patients co-infected with hepatitis C using an anti-retroviral drug therapy.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 6 days ago
| Entity Name | South Florida Ent Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184625733 PECOS PAC ID: 4587556923 Enrollment ID: O20040329001213 |
News Archive
Mylan N.V. and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding to its existing offering of Fentanyl Transdermal System 12, 25, 50, 75 and 100 mcg/hr.
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded a two-year grant to Dr. Brian L. Schmidt, professor of oral and maxillofacial surgery at the NYU College of Dentistry, and Dr. Donna G. Albertson, professor at the UCSF Helen Diller Family Comprehensive Cancer Center. The grant will fund groundbreaking research to customize treatment for oral cancer patients.
Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.
The Black Death swept Europe in the 14th century eliminating up to half of the population but it left genetic clues that now may aid a University of Cincinnati researcher in treating HIV patients co-infected with hepatitis C using an anti-retroviral drug therapy.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Michael Zaki, MD 15280 Nw 79th Ct Ste 200, Miami Lakes, FL 33016-5873 Ph: (305) 558-3724 | Michael Zaki, MD 21097 Ne 27th Ct Ste 410, Aventura, FL 33180-1249 Ph: (305) 932-6375 |
News Archive
Mylan N.V. and Mylan Inc. today announced the U.S. launch of its Fentanyl Transdermal System 37.5, 62.5 and 87.5 mcg/hr, adding to its existing offering of Fentanyl Transdermal System 12, 25, 50, 75 and 100 mcg/hr.
The National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has awarded a two-year grant to Dr. Brian L. Schmidt, professor of oral and maxillofacial surgery at the NYU College of Dentistry, and Dr. Donna G. Albertson, professor at the UCSF Helen Diller Family Comprehensive Cancer Center. The grant will fund groundbreaking research to customize treatment for oral cancer patients.
Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.
The Black Death swept Europe in the 14th century eliminating up to half of the population but it left genetic clues that now may aid a University of Cincinnati researcher in treating HIV patients co-infected with hepatitis C using an anti-retroviral drug therapy.
NPS Pharmaceuticals, Inc. today announced that it intends to offer, subject to market and other conditions, 7,500,000 shares of its common stock in an underwritten public offering. In connection with this offering, the Company expects to grant to the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock to cover overallotments, if any.
› Verified 6 days ago
Oliver Yonzen Chin, M.D. Otolaryngology Medicare: May Accept Medicare Assignments Practice Location: 21097 Ne 27th Ct Ste 410, Aventura, FL 33180 Phone: 305-932-6375 Fax: 305-932-9002 | |
Jadrien Young, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21550 Biscayne Blvd Ste 202a, Aventura, FL 33180 Phone: 305-707-0368 Fax: 786-533-1672 | |
Dr. Jeremy Boyd White, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 20950 Ne 27th Ct Ste 302, Arc Plastic Surgery, Aventura, FL 33180 Phone: 305-501-2000 Fax: 954-603-1151 | |
Moises Mitrani, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21150 Biscayne Blvd, # 102, Aventura, FL 33180 Phone: 305-935-6000 Fax: 305-935-6248 | |
Carl Drucker, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 21150 Biscayne Blvd, #102, Aventura, FL 33180 Phone: 305-935-6000 Fax: 305-935-6248 |